Author:
Yang Dandan,Zhang Chuanfeng,Chen Yuheng,Lu Jing,Chen Yunting,Zhang Zhi,Chai Feifei,Zhang Zhendong,Wang Furu,Zhu Baoli
Abstract
ObjectiveThis study aimed to evaluate the spatiotemporal distribution of patients with hepatitis C virus (HCV) and the factors influencing this distribution in Jiangsu Province, China, from 2011 to 2020.MethodsThe incidence of reported HCV in Jiangsu Province from 2011 to 2020 was obtained from the Chinese Information System for Disease Control and Prevention (CISDCP). R and GeoDa software were used to visualize the spatiotemporal distribution and the spatial autocorrelation of HCV. A Bayesian spatiotemporal model was constructed to explore the spatiotemporal distribution of HCV in Jiangsu Province and to further analyze the factors related to HCV.ResultsA total of 31,778 HCV patients were registered in Jiangsu Province. The registered incidence rate of HCV increased from 2.60/100,000 people in 2011 to 4.96/100,000 people in 2020, an increase of 190.77%. Moran's I ranged from 0.099 to 0.354 (P < 0.05) from 2011 to 2019, indicating a positive spatial correlation overall. The relative risk (RR) of the urbanization rate, the most important factor affecting the spread of HCV in Jiangsu Province, was 1.254 (95% confidence interval: 1.141–1.376), while other factors had no significance.ConclusionThe reported HCV incidence rate integrally increased in the whole Jiangsu Province, whereas the spatial aggregation of HCV incidence was gradually weakening. Our study highlighted the importance of health education for the floating population and reasonable allocation of medical resources in the future health work.
Reference30 articles.
1. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis;Gao;BMC Infect Dis.,2011
2. Hepatitis C virus and hepatocellular carcinoma: when the host loses its grip;Goto;Int J Mol Sci.,2020
3. Hepatitis C2023
4. New WHO study: Making diagnosis of hepatitis C more accessible and closer to the community using point-of-care HCV viral load assays2023
5. Global hepatitis report, 20172017